<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>GLP-1 WHO 2026 Compliance Pack ‚Äì Clinic & Telehealth Guidance</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description"
        content="WHO 2026 GLP-1 global risk advisory compliance guide for clinics, telehealth platforms, pharmacies and compounders ‚Äì eligibility, off-label documentation, cold-chain logs, supplier verification and audit-ready workflows." />
  <meta name="robots" content="index,follow" />
  <link rel="icon" href="/favicon.ico" />
  <link rel="canonical" href="https://skillona.ai/glp1-who-guidance-2026/" />
  <meta name="date" content="2026-01-01" />

  <!-- Open Graph -->
  <meta property="og:title" content="GLP-1 WHO 2026 Compliance Pack ‚Äì Clinic & Telehealth Guidance" />
  <meta property="og:description"
        content="Practical WHO 2026 GLP-1 compliance system for clinics, telehealth, pharmacies and compounders ‚Äì documentation templates, logs and audit-ready checklists." />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="https://skillona.ai/glp1-who-guidance-2026/" />
  <meta property="og:image" content="https://skillona.ai/assets/og/glp1-who-guidance-2026.png" />
  <meta property="og:site_name" content="Skillona.ai" />

  <!-- Twitter -->
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:title" content="GLP-1 WHO 2026 Compliance Pack ‚Äì Clinic & Telehealth Guidance" />
  <meta name="twitter:description"
        content="Done-for-you WHO 2026 GLP-1 compliance framework for prescribers, pharmacies and compounding partners." />
  <meta name="twitter:image" content="https://skillona.ai/assets/og/glp1-who-guidance-2026.png" />

  <style>
    :root {
      --bg: #050814;
      --bg-elevated: #0b1220;
      --bg-soft: #101827;
      --accent: #38bdf8;
      --accent-soft: rgba(56, 189, 248, 0.12);
      --text: #e5e7eb;
      --muted: #9ca3af;
      --border-subtle: #1f2937;
      --danger: #f97373;
      --success: #4ade80;
      --radius-lg: 18px;
      --radius-xl: 26px;
      --shadow-soft: 0 18px 45px rgba(0, 0, 0, 0.55);
      --max-width: 900px;
    }

    * {
      box-sizing: border-box;
      -webkit-font-smoothing: antialiased;
      text-rendering: optimizeLegibility;
    }

    body {
      margin: 0;
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "SF Pro Text",
        "Segoe UI", sans-serif;
      background: radial-gradient(circle at top, #111827 0, #020617 55%, #000 100%);
      color: var(--text);
      min-height: 100vh;
      display: flex;
      justify-content: center;
    }

    .page {
      width: 100%;
      max-width: var(--max-width);
      padding: 28px 18px 40px;
    }

    @media (min-width: 768px) {
      .page {
        padding: 40px 0 64px;
      }
    }

    .shell {
      background: linear-gradient(145deg, rgba(15, 23, 42, 0.96), rgba(2, 6, 23, 0.98));
      border-radius: 32px;
      padding: 28px 20px 30px;
      box-shadow: var(--shadow-soft);
      border: 1px solid rgba(148, 163, 184, 0.16);
      backdrop-filter: blur(26px);
    }

    @media (min-width: 768px) {
      .shell {
        padding: 32px 36px 38px;
      }
    }

    header {
      display: flex;
      flex-direction: column;
      gap: 12px;
      margin-bottom: 26px;
    }

    .tagline {
      font-size: 13px;
      letter-spacing: 0.16em;
      text-transform: uppercase;
      color: var(--muted);
      display: flex;
      align-items: center;
      gap: 10px;
      flex-wrap: wrap;
    }

    .tagline-pill {
      padding: 4px 10px;
      border-radius: 999px;
      background: rgba(15, 23, 42, 0.9);
      border: 1px solid var(--border-subtle);
      display: inline-flex;
      align-items: center;
      gap: 6px;
    }

    .tag-dot {
      width: 6px;
      height: 6px;
      border-radius: 999px;
      background: var(--accent);
      box-shadow: 0 0 0 4px var(--accent-soft);
    }

    h1 {
      font-size: 26px;
      line-height: 1.15;
      letter-spacing: -0.03em;
      margin: 0;
    }

    @media (min-width: 768px) {
      h1 {
        font-size: 32px;
      }
    }

    .subtitle {
      color: var(--muted);
      font-size: 15px;
      max-width: 640px;
    }

    .meta-row {
      display: flex;
      flex-wrap: wrap;
      gap: 10px;
      margin-top: 6px;
      font-size: 12px;
      color: var(--muted);
    }

    .meta-pill {
      padding: 4px 9px;
      border-radius: 999px;
      border: 1px solid var(--border-subtle);
      background: rgba(15, 23, 42, 0.85);
      display: inline-flex;
      align-items: center;
      gap: 6px;
    }

    .meta-pill strong {
      font-weight: 600;
      color: #e5e7eb;
    }

    main {
      display: grid;
      grid-template-columns: minmax(0, 1.9fr) minmax(0, 1.1fr);
      gap: 18px;
    }

    @media (max-width: 900px) {
      main {
        grid-template-columns: minmax(0, 1fr);
      }
    }

    .article {
      background:
        radial-gradient(circle at top left, rgba(56, 189, 248, 0.12), transparent 55%),
        radial-gradient(circle at bottom right, rgba(129, 140, 248, 0.12), transparent 52%),
        linear-gradient(145deg, #020617, #020617);
      border-radius: var(--radius-xl);
      border: 1px solid rgba(55, 65, 81, 0.9);
      padding: 20px 18px 22px;
      position: relative;
      overflow: hidden;
    }

    @media (min-width: 768px) {
      .article {
        padding: 22px 22px 24px;
      }
    }

    .article::before {
      content: "";
      position: absolute;
      inset: 0;
      background: radial-gradient(circle at top right, rgba(59, 130, 246, 0.18), transparent 60%);
      opacity: 0.7;
      pointer-events: none;
      mix-blend-mode: soft-light;
    }

    .article-inner {
      position: relative;
      z-index: 1;
    }

    .section-label {
      font-size: 11px;
      letter-spacing: 0.16em;
      text-transform: uppercase;
      color: var(--muted);
      margin-bottom: 6px;
    }

    .article h2 {
      font-size: 18px;
      margin-top: 20px;
      margin-bottom: 8px;
      letter-spacing: -0.02em;
    }

    .article h3 {
      font-size: 15px;
      margin-top: 16px;
      margin-bottom: 6px;
    }

    .article p {
      font-size: 14px;
      line-height: 1.6;
      color: #d1d5db;
      margin: 6px 0 8px;
    }

    .article ul,
    .article ol {
      margin: 6px 0 10px 0;
      padding-left: 18px;
      font-size: 14px;
      color: #d1d5db;
    }

    .article li {
      margin-bottom: 5px;
    }

    .callout {
      margin: 14px 0 12px;
      padding: 10px 12px;
      border-radius: 14px;
      background: rgba(15, 23, 42, 0.96);
      border: 1px solid rgba(55, 65, 81, 0.95);
      font-size: 13px;
      color: #e5e7eb;
      display: flex;
      gap: 10px;
      align-items: flex-start;
    }

    .callout-icon {
      width: 18px;
      height: 18px;
      border-radius: 999px;
      background: var(--accent-soft);
      border: 1px solid var(--accent);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 11px;
      color: var(--accent);
      flex-shrink: 0;
      margin-top: 2px;
    }

    .checklist {
      border-radius: 16px;
      border: 1px dashed rgba(75, 85, 99, 0.9);
      padding: 10px 12px;
      margin-top: 10px;
      background: rgba(15, 23, 42, 0.9);
    }

    .checklist h3 {
      margin-top: 0;
      font-size: 14px;
    }

    .checklist ul {
      margin: 4px 0 0;
      padding-left: 18px;
    }

    .checklist li::marker {
      content: "‚úì ";
      color: var(--success);
      font-weight: 600;
    }

    .faq {
      margin-top: 16px;
      border-top: 1px solid rgba(31, 41, 55, 0.9);
      padding-top: 10px;
    }

    .faq-item + .faq-item {
      margin-top: 8px;
    }

    .faq-q {
      font-size: 14px;
      font-weight: 600;
      margin-bottom: 2px;
    }

    .faq-a {
      font-size: 13px;
      color: var(--muted);
    }

    .sidebar {
      display: flex;
      flex-direction: column;
      gap: 14px;
    }

    .sidebar-card {
      background:
        radial-gradient(circle at top left, rgba(56, 189, 248, 0.18), transparent 55%),
        linear-gradient(145deg, #020617, #020617);
      border-radius: var(--radius-xl);
      border: 1px solid rgba(55, 65, 81, 0.95);
      padding: 14px 14px 16px;
    }

    .sidebar-card h3 {
      margin: 0 0 8px;
      font-size: 14px;
    }

    .sidebar-card p {
      margin: 0 0 10px;
      font-size: 13px;
      color: var(--muted);
    }

    .badge {
      display: inline-flex;
      align-items: center;
      gap: 6px;
      padding: 3px 8px;
      border-radius: 999px;
      background: rgba(15, 23, 42, 0.9);
      border: 1px solid rgba(55, 65, 81, 0.9);
      font-size: 11px;
      text-transform: uppercase;
      letter-spacing: 0.16em;
      color: var(--muted);
      margin-bottom: 6px;
    }

    .badge span {
      font-size: 8px;
      color: var(--accent);
    }

    .link-list {
      list-style: none;
      padding: 0;
      margin: 0;
      font-size: 13px;
    }

    .link-list li + li {
      margin-top: 4px;
    }

    .link-list a {
      color: #e5e7eb;
      text-decoration: none;
    }

    .link-list a:hover {
      color: var(--accent);
    }

    .ad-slot {
      margin-top: 8px;
      border-radius: 14px;
      border: 1px dashed rgba(75, 85, 99, 0.9);
      padding: 10px 8px;
      font-size: 11px;
      text-align: center;
      color: var(--muted);
      background: rgba(15, 23, 42, 0.92);
    }

    .ad-slot.small {
      padding: 6px 6px;
      font-size: 10px;
    }

    footer {
      margin-top: 26px;
      padding-top: 16px;
      border-top: 1px solid var(--border-subtle);
      font-size: 11px;
      color: var(--muted);
      display: flex;
      flex-wrap: wrap;
      justify-content: space-between;
      gap: 8px;
    }

    footer a {
      color: var(--muted);
      text-decoration: none;
    }

    footer a:hover {
      color: var(--accent);
    }

    .btn-primary {
      display: inline-flex;
      align-items: center;
      justify-content: center;
      margin-top: 6px;
      padding: 9px 14px;
      border-radius: 999px;
      background: var(--accent);
      color: #0b1120;
      font-size: 13px;
      font-weight: 600;
      text-decoration: none;
      box-shadow: 0 0 0 1px rgba(8, 47, 73, 0.7),
                  0 14px 30px rgba(56, 189, 248, 0.35);
    }

    .btn-primary:hover {
      filter: brightness(1.05);
    }
  </style>
</head>

<body>
  <div class="page">
    <div class="shell">

      <header>
        <div class="tagline">
          <div class="tagline-pill">
            <span class="tag-dot"></span>
            WHO ¬∑ 2026 GLP-1 GLOBAL RISK ADVISORY
          </div>
          <span>Skillona.ai ¬∑ Compliance micro-guide ¬∑ Updated January 2026</span>
        </div>
        <h1>GLP-1 WHO 2026 Compliance Pack ‚Äì For Clinics, Telehealth & Pharmacies</h1>
        <p class="subtitle">
          In January 2026 the WHO issued a GLP-1 Global Risk Advisory covering semaglutide, tirzepatide,
          compounded GLP-1 products and grey-market supply. Regulators, insurers and manufacturers are tightening
          prescribing, off-label use, cold-chain and marketing rules. This page shows you exactly what changed ‚Äì
          and how the GLP-1 WHO 2026 Compliance Pack keeps your organisation audit-ready.
        </p>
        <div class="meta-row">
          <div class="meta-pill">‚è±Ô∏è <strong>Reading time:</strong>&nbsp;8‚Äì12 min</div>
          <div class="meta-pill">üè• <strong>Built for:</strong>&nbsp;clinics ¬∑ telehealth ¬∑ pharmacies ¬∑ compounders</div>
          <div class="meta-pill">üìë <strong>Pack:</strong>&nbsp;25-page PDF + forms &amp; logs</div>
        </div>
      </header>

      <main>
        <article class="article">
          <div class="article-inner">

            <div class="section-label">Overview</div>
            <h2>1. What changed in the WHO 2026 GLP-1 advisory</h2>
            <p>
              The advisory focuses on four global risk clusters that have exploded with mass GLP-1 adoption:
            </p>
            <ul>
              <li><strong>Counterfeit &amp; grey-market product</strong> from online and cross-border channels.</li>
              <li><strong>Contaminated / wrong-potency batches</strong>, especially in non-accredited compounding.</li>
              <li><strong>Aggressive off-label expansion</strong> without documentation or consent.</li>
              <li><strong>Breaks in cold-chain integrity</strong> with no logs or deviation handling.</li>
            </ul>
            <p>
              The result: more audits, payer reviews and licence scrutiny for any GLP-1 prescriber, clinic,
              pharmacy or compounding partner.
            </p>

            <div class="callout">
              <div class="callout-icon">!</div>
              <div>
                The Compliance Pack is designed so you can go from ‚Äúwe have no system‚Äù to
                <strong>fully documented, WHO-aligned workflows in a single afternoon</strong>.
              </div>
            </div>

            <div class="section-label">Documentation</div>
            <h2>2. Core compliance documentation you now need</h2>
            <p>
              Under the advisory, you are expected to maintain end-to-end documentation for every GLP-1 patient and batch.
              At minimum:
            </p>
            <ul>
              <li>Patient eligibility &amp; prescribing rationale.</li>
              <li>Informed consent ‚Äì especially for off-label use.</li>
              <li>Supply-chain verification &amp; COAs.</li>
              <li>Cold-chain temperature logs and deviation handling.</li>
              <li>Adverse event reports with escalation trail.</li>
              <li>Marketing &amp; claims review logs.</li>
            </ul>

            <div class="checklist">
              <h3>What the PDF pack gives you, ready-to-use</h3>
              <ul>
                <li>GLP-1 eligibility checklist &amp; form.</li>
                <li>Off-label informed-consent template.</li>
                <li>Cold-chain log + deviation procedure.</li>
                <li>Supplier &amp; compounding verification sheets.</li>
                <li>Adverse event reporting form.</li>
                <li>Marketing &amp; claims review checklist.</li>
              </ul>
            </div>

            <div class="section-label">Off-label &amp; consent</div>
            <h2>3. Off-label GLP-1 use ‚Äì new 2026 expectations</h2>
            <p>
              Off-label GLP-1 prescribing remains legal in many jurisdictions, but it is now a primary audit trigger.
              The advisory expects you to:
            </p>
            <ul>
              <li>Record a clear, written off-label rationale for every patient.</li>
              <li>Obtain signed informed consent with alternatives explained.</li>
              <li>Document expectations, monitoring schedule and risk profile.</li>
              <li>Store this documentation for a minimum of five years.</li>
            </ul>
            <p>
              The pack includes a copy-paste informed-consent template so your clinicians don‚Äôt start from a blank page.
            </p>

            <div class="section-label">Cold chain &amp; supply</div>
            <h2>4. Cold-chain and supplier verification</h2>
            <p>
              Breaks in storage and weak supplier checks are now viewed as systemic risk, not minor operational issues.
              You are expected to:
            </p>
            <ul>
              <li>Run continuous temperature monitoring with 24/7 logs.</li>
              <li>Quarantine and document any cold-chain deviation.</li>
              <li>Collect and file COAs and batch testing reports.</li>
              <li>Verify licences and accreditations for all suppliers and compounders.</li>
            </ul>

            <div class="checklist">
              <h3>Included operational templates</h3>
              <ul>
                <li>Cold-chain log (batch ID, timestamp, temperature, staff initials).</li>
                <li>Deviation procedure checklist.</li>
                <li>Supplier verification form.</li>
                <li>Compounded product verification template.</li>
              </ul>
            </div>

            <div class="section-label">Adverse events &amp; audits</div>
            <h2>5. Adverse event reporting and audit preparation</h2>
            <p>
              The advisory expects structured adverse-event capture and escalation, plus a defined emergency response
              if you receive an audit notice.
            </p>
            <ul>
              <li>Standardised event form (type, severity, batch, timing, action taken).</li>
              <li>Clear routing: manufacturer, regulator, WHO / national body.</li>
              <li>Audit red-flags: undocumented off-label use, missing cold-chain logs, high compounder volume, no COAs.</li>
            </ul>
            <p>
              The pack includes a one-page emergency response plan so staff know exactly what to freeze, pull and send within
              the audit timeframe.
            </p>

            <div class="section-label">Download</div>
            <h2>6. Download the GLP-1 WHO 2026 Compliance Pack (PDF)</h2>
            <p>
              The pack is designed so a compliance lead or clinic owner can implement a complete GLP-1 documentation
              framework without hiring consultants.
            </p>
            <ul>
              <li>25-page WHO-aligned compliance PDF.</li>
              <li>Eligibility &amp; consent forms.</li>
              <li>Cold-chain and supplier logs.</li>
              <li>Adverse-event and marketing review checklists.</li>
              <li>Final one-page ‚Äúall-items-checked‚Äù compliance checklist.</li>
            </ul>
            <a class="btn-primary" href="https://branimirvrnoga.gumroad.com/l/WHOGLP-12026guidance" target="_blank">
              Download the GLP-1 WHO 2026 Compliance Pack (Gumroad)
            </a>

            <div class="section-label">FAQ</div>
            <h2>7. Quick FAQ for clinics &amp; telehealth</h2>

            <div class="faq">
              <div class="faq-item">
                <div class="faq-q">Who is this pack designed for?</div>
                <div class="faq-a">
                  Outpatient clinics, tele-health platforms, pharmacies, compounding partners and distributors
                  that prescribe, dispense or manage GLP-1 products.
                </div>
              </div>

              <div class="faq-item">
                <div class="faq-q">Is this legal or regulatory advice?</div>
                <div class="faq-a">
                  No. It is a practical documentation framework based on WHO‚Äôs 2026 advisory and common regulatory expectations.
                  Local law and regulator guidance always control.
                </div>
              </div>

              <div class="faq-item">
                <div class="faq-q">Can patients use this pack directly?</div>
                <div class="faq-a">
                  Parts of it (education sheet, titration overview) are patient-friendly, but the pack is primarily
                  built for professional use inside a clinic, pharmacy or tele-health workflow.
                </div>
              </div>

              <div class="faq-item">
                <div class="faq-q">How quickly can we implement it?</div>
                <div class="faq-a">
                  Most small teams can adapt the templates, set up logs and brief staff in a single afternoon,
                  then refine over time as regulators or payers update requirements.
                </div>
              </div>
            </div>

          </div>
        </article>

        <aside class="sidebar">
          <div class="sidebar-card">
            <div class="badge"><span>‚óè</span> CLINIC TOOLKIT</div>
            <h3>GLP-1 Documentation Starter Stack</h3>
            <p>
              Use the pack as your default GLP-1 paperwork: eligibility, consent, supply-chain, cold-chain and adverse events.
              Drop into existing SOPs with minimal edits.
            </p>
            <div class="ad-slot small">
              Included in the PDF: all core forms and logs in ready-to-print layout.
            </div>
          </div>

          <div class="sidebar-card">
            <h3>Where this fits in your risk strategy</h3>
            <p>
              Combine the pack with your existing quality management system, insurer requirements and local regulator guidance.
            </p>
            <ul class="link-list">
              <li><a href="https://branimirvrnoga.gumroad.com/l/WHOGLP-12026guidance" target="_blank">Get the Compliance Pack ‚Üí</a></li>
            </ul>
          </div>

          <div class="sidebar-card">
            <h3>Related compliance micro-guides</h3>
            <ul class="link-list">
              <li><a href="/medical-bill-overcharge-charity-care/">Medical Bill Overcharge &amp; Charity Care ‚Äì Reduce hospital exposure</a></li>
              <li><a href="/background-check-dispute/">Background Check Dispute ‚Äì Fix screening data</a></li>
              <li><a href="/us-credit-report-error-dispute/">U.S. Credit Report Error Dispute ‚Äì Full deletion guide</a></li>
            </ul>
          </div>

          <div class="sidebar-card">
            <div class="badge"><span>‚óè</span> ADS / AFFILIATE</div>
            <h3>Optional partner slot</h3>
            <p>Space for GLP-1 audit software, QMS tools or specialist legal/compliance advisory.</p>
            <div class="ad-slot">Ad placeholder ‚Äì GLP-1 compliance services.</div>
          </div>
        </aside>
      </main>

      <div class="ad-slot" style="margin-top:22px;">
        Bottom banner placeholder ‚Äì GLP-1 compliance / healthcare SaaS affiliate.
      </div>

      <footer>
        <div>¬© 2026 Skillona.ai ¬∑ Educational only. Not legal, regulatory or medical advice.</div>
        <div>
          <a href="/about.html">About</a> ¬∑
          <a href="/disclaimer.html">Disclaimer</a> ¬∑
          <a href="/contact.html">Contact</a>
        </div>
      </footer>
    </div>
  </div>
</body>
</html>
